The use of hormonal contraception among women taking anticonvulsant therapy

Contraception

Volumn 83, Issue 1, 2011, Pages 16-29

  Gaffield, Mary E ^a   Culwell, Kelly R ^a   Lee, C Rhoda ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b ROYAL PHARMACEUTICAL SOCIETY   (United Kingdom)

Author keywords

Anticonvulsants; Antiepileptic drugs; Contraceptive methods; Drug interactions; Estrogen; Progestogen

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORGESTIMATE; ETIRACETAM; ETONOGESTREL; FELBAMATE; FOLLITROPIN; GESTAGEN; LAMOTRIGINE; LEVONORGESTREL; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROGESTERONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ANTICONVULSANT THERAPY; AREA UNDER THE CURVE; ARTICLE; DRUG CLEARANCE; DRUG EFFICACY; DRUG MEGADOSE; EPILEPSY; HORMONAL CONTRACEPTION; HUMAN; SEIZURE; SYSTEMATIC REVIEW;

EID: 78649904394     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.06.013     Document Type: Review

References (49)

1. Kenyon T.E. Unplanned pregnancy in an epileptic Br Med J 1 1972 686 687
2. Zhang H., Cui D., and Wong B. Pharmacokinetic drug interactions involving 17á-ethinylestradiol Clin Pharmacokinet 46 2007 133 157
3. Perucca E. Birth defects after prenatal exposure to antiepileptic drugs Lancet Neurol 4 2005 781 786
4. Tomson T., and Battino D. Pregnancy and epilepsy: what should we tell our patients? J Neurol 2007
5. Patsalos P.N., Froscher W., Pisani F., and van Rijn C.M. The importance of drug interactions in epilepsy therapy Epilepsia 43 2002 365 385
6. Christensen J., Petrenaite V., Atterman J., Sidenius P., Ohman I., and Tomson T. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial Epilepsia 48 2007 484 489
7. Tomson T., Luef G., Sabers A., Pittschieler S., and Ohman I. Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives Neurology 67 2006 1297 1299
8. World Health Organization Medical Eligibility Criteria for Contraceptive Use 3rd ed. 2004 World Health Organization Geneva, Switzerland
9. Mohllajee A.P., Curtis K.M., Flannagan R.G., Rinehart W., Gaffield M.E., and Peterson H.B. Keeping up with evidence: a new system for WHOs' evidence-based family planning guidance Am J Prev Med 28 2005 483 490
10. Harris R.P. Current methods of the US Preventive Services Task Force: a review of the process Am J Prev Med 20 2001 21 25
11. Back D.J., Bates M., and Bowden A. The interaction of Phenobarbital and other anticonvulsants with oral contraceptive steroid therapy Contraception 22 1980 495 503
12. Back D.J., Grimmer F.M., Orme M.L., Proudlove C., Mann R.D., and Breckenridge A.M. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics Br J Clin Pharmacol 25 1988 527 532
13. Belaisch J., Driguez P., and Janaud A. Influence de certains médicaments sur l'action des pilules contraceptives Nouv Presse Med 4 1976 3008
14. Contin M., Albani F., and Ambrosetto G. Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy Epilepsia 47 2006 1573 1575
15. Coulam C.B., and Annegers J.F. Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 20 1979 519 526
16. Crawford P., Chadwick D., and Cleland P. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids Contraception 33 1986 23 29
17. Crawford P., Chadwick D.J., Martin C., Tjia J., Back D.J., and Orme M. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids Br J Clin Pharmacol 30 1990 892 896
18. Fanoe E. P-pillesvigt-antagelig pa grund af interaktion med fenemal Ugeskr Laeger 139 1977 1485
19. Gagnaire J.C., Tchertchian J., Revol A., and Rochet Y. Grossesses sous contraceptifs oraux chez les patientes recevant des barbituriques Nouv Presse Med 4 1975 3008
20. Galimberti C.A., Mazzucchelli I., Arbasino C., Canevini M.P., Fattore C., and Pericca E. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy Epilepsia 47 2006 1569 1572
21. Hempel E., Böhm W., Carol W., and Klinger G. Medikamentöse Enzyminduktion und hormonale Kontrazeption Zentralbl Gynakol 95 1973 1451 1457
22. Hempel E., and Klinger G. Drug stimulated biotransformation of hormonal steroid contraceptives: clinical implications Drugs 12 1976 442 448
23. Herzog A.G., Farina E.L., and Blum A.S. Serum valproate levels with oral contraceptive use Epilepsia 46 2005 970 971
24. Herzog A.G., Blum A.S., and Farina E.L. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use Neurology 72 2009 911 914
25. Janz D., and Schmidt D. Anti-epileptic drugs and failure of oral contraceptives Lancet 1 1974 1113
26. Janz D., and Schmidt D. Antiepileptika und die sicherheit oraler kontrazeptiva Bibl Psychiatr 151 1975 82 85
27. Kovacs G.T., Riddoch G., and Duncombe P. Inadvertent pregnancies in oral contraceptive users Med J Aust 150 1989 549 551
28. Ohman I., Luef G., and Tomson T. Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites Seizure 17 2008 199 202
29. Reimers A., Helde G., and Brodtkorb E. Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations Epilepsia 46 2005 1414 1417
30. Rosenfeld W.E., Doose D.R., Walker S.A., and Nayak R.K. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy Epilepsia 38 1997 317 323
31. Sabers A., Buchholt J.M., Uldall P., and Hansen E.L. Lamotrigine plasma levels reduced by oral contraceptives Epilepsy Res 47 2001 151 154
32. Sabers A., Ohman I., Christensen J., and Tomson T. Oral contraceptives reduce lamotrigine plasma levels Neurology 61 2003 570 571
33. van der Graaf W.T., van Loon A.J., Postmus P.E., and Sleijfer D.T. Twee patiënten met hersenmetastasen die zwanger werden tijedens fenytoïnegebruik Ned Tijdschr Geneeskd 136 1992 2236 2238
34. Wegner I., Edelbroek P.M., Bulk S., and Lindhout D. Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives Neurology 73 2009 1388 1393
35. Haukkamaa M. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on treatment on anticonvulsant treatment Contraception 33 1986 559 565
36. Odlind V., and Olsson S.E. Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants Contraception 33 1986 257 261
37. Schindlbeck C., Janni W., and Friese K. Failure of Implanon contraception in a patient taking carbamazepine for epilepsia Arch Gynecol Obstet 273 2006 255 256
38. Shane-McWhorter L., Cerveny J.D., MacFarlane L.L., and Osborn C. Enhanced metabolism of levonorgestrel during phenobarbital treatment and resultant pregnancy Pharmacotherapy 18 1998 1360 1364
39. Bounds W., and Guillebaud J. Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs J Fam Plann Reprod Health Care 28 2002 78 80
40. Bartoli A., Gatti G., and Cipolla G. A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers Epilepsia 38 1997 702 707
41. Doose D.R., Wang S., Padmanabhan M., Schwabe S., Jacobs D., and Bialer M. Effects of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects Epilepsia 44 2003 540 549
42. Eldon M.A., Underwood B.A., Randinitis E.J., and Sedman A.J. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol Neurology 50 1998 1146 1148
43. Fattore C., Cipolla G., and Gatti G. Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women Epilepsia 40 1999 783 787
44. Griffith S.G., and Dai Y. Effect of Zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women Clin Ther 26 2004 2056 2064
45. Mengel H.B., Houston A., and Back D.J. An evaluation of the interaction between tiagabine and oral contraceptives in female volunteers J Pharm Med 4 1994 141 150
46. Ragueneau-Majlessi I., Levy R.H., and Janik F. Levetiracetum does not alter the pharmacokinetics of an oral contraceptive in healthy women Epilepsia 43 2002 697 702
47. Saano V., Glue P., and Banfield C.R. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive Clin Pharmacol Ther 58 1995 523 531
48. Sidhu J., Job S., Singh S., and Philipson R. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects Br J Clin Pharmacol 61 2 2005 191 199
49. Sparrow M.J. Pill method failures N Z Med J 100 1987 102 105